Last updated on August 2014


Brief description of study


Detailed Study Description

A Prospective, Randomized, Open-Label Blinded Endpont Evaluation (PROBE) Parallel Group Study Comparing Edoxaban (DU-176b) With Enoxaparin/Warfarin Followed by Warfarin Alone in subjects undergoing planned electrical Cardioversion of Nonvalvular Atrial Fibrillation

Clinical Study Identifier: TX138951

Contact Investigators or Research Sites near you

Start Over
Sorry. There are no research Sites conducting this study in the radius provided. ( View all Sites )